ATA66799A - Neue medizinische verwendung von alpha1-saurem glykoprotein - Google Patents

Neue medizinische verwendung von alpha1-saurem glykoprotein

Info

Publication number
ATA66799A
ATA66799A AT0066799A AT66799A ATA66799A AT A66799 A ATA66799 A AT A66799A AT 0066799 A AT0066799 A AT 0066799A AT 66799 A AT66799 A AT 66799A AT A66799 A ATA66799 A AT A66799A
Authority
AT
Austria
Prior art keywords
medical use
new medical
acid glycoprotein
alpha1
alpha1 acid
Prior art date
Application number
AT0066799A
Other languages
English (en)
Other versions
AT407485B (de
Inventor
Konstantin Dr Hiotakis
Herwig Ernst Mag Reichl
Original Assignee
Haemosan Erzeugung Pharmazeuti
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Haemosan Erzeugung Pharmazeuti filed Critical Haemosan Erzeugung Pharmazeuti
Priority to AT0066799A priority Critical patent/AT407485B/de
Priority to CA002369472A priority patent/CA2369472A1/en
Priority to EP00918560A priority patent/EP1171153A2/de
Priority to PCT/AT2000/000090 priority patent/WO2000061170A2/de
Priority to AU39453/00A priority patent/AU3945300A/en
Priority to JP2000610502A priority patent/JP2002541209A/ja
Publication of ATA66799A publication Critical patent/ATA66799A/de
Application granted granted Critical
Publication of AT407485B publication Critical patent/AT407485B/de
Priority to US09/978,317 priority patent/US20020147137A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/36—Opioid-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Addiction (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Toxicology (AREA)
  • Psychiatry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
AT0066799A 1999-04-14 1999-04-14 Neue medizinische verwendung von alpha1-saurem glykoprotein AT407485B (de)

Priority Applications (7)

Application Number Priority Date Filing Date Title
AT0066799A AT407485B (de) 1999-04-14 1999-04-14 Neue medizinische verwendung von alpha1-saurem glykoprotein
CA002369472A CA2369472A1 (en) 1999-04-14 2000-04-14 Novel medical use of alpha-1-acidic glycoprotein (aag or orosomucoid)
EP00918560A EP1171153A2 (de) 1999-04-14 2000-04-14 Neue medizinische verwendung von alpha-1-saurem glykoprotein (aag oder orosomucoid)
PCT/AT2000/000090 WO2000061170A2 (de) 1999-04-14 2000-04-14 Neue medizinische verwendung von alpha-1-saurem glykoprotein (aag oder orosomucoid)
AU39453/00A AU3945300A (en) 1999-04-14 2000-04-14 Novel medical use of alpha1-acidic glycoprotein (aag) or orosomucoid
JP2000610502A JP2002541209A (ja) 1999-04-14 2000-04-14 α１酸性糖タンパク質（ＡＡＧ）又はオロソムコイドの新規な医学的使用
US09/978,317 US20020147137A1 (en) 1999-04-14 2001-10-15 Medical use of alpha1-acid glycoprotein (AAG) or orosomucoid

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AT0066799A AT407485B (de) 1999-04-14 1999-04-14 Neue medizinische verwendung von alpha1-saurem glykoprotein

Publications (2)

Publication Number Publication Date
ATA66799A true ATA66799A (de) 2000-08-15
AT407485B AT407485B (de) 2001-03-26

Family

ID=3496646

Family Applications (1)

Application Number Title Priority Date Filing Date
AT0066799A AT407485B (de) 1999-04-14 1999-04-14 Neue medizinische verwendung von alpha1-saurem glykoprotein

Country Status (7)

Country Link
US (1) US20020147137A1 (de)
EP (1) EP1171153A2 (de)
JP (1) JP2002541209A (de)
AT (1) AT407485B (de)
AU (1) AU3945300A (de)
CA (1) CA2369472A1 (de)
WO (1) WO2000061170A2 (de)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111157738A (zh) * 2019-12-28 2020-05-15 王贤俊 一种提高检测血清α1-酸性糖蛋白检测灵敏度的方法

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102578590B (zh) * 2011-01-06 2014-04-09 中国人民解放军第二军医大学 α1-酸性糖蛋白的应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT408191B (de) * 1991-08-19 2001-09-25 Haemosan Erzeugung Pharmazeuti Verfahren zur inaktivierung von prionen
GB9604921D0 (en) * 1996-03-08 1996-05-08 Nat Blood Authority Purification method
AT405241B (de) * 1997-03-10 1999-06-25 Immuno Ag Verwendung von humanem alpha1-sauren glycoprotein zur herstellung einer pharmazeutischen präparation

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111157738A (zh) * 2019-12-28 2020-05-15 王贤俊 一种提高检测血清α1-酸性糖蛋白检测灵敏度的方法

Also Published As

Publication number Publication date
JP2002541209A (ja) 2002-12-03
WO2000061170A2 (de) 2000-10-19
US20020147137A1 (en) 2002-10-10
CA2369472A1 (en) 2000-10-19
AT407485B (de) 2001-03-26
AU3945300A (en) 2000-11-14
WO2000061170A3 (de) 2001-05-10
EP1171153A2 (de) 2002-01-16

Similar Documents

Publication Publication Date Title
DE69927128T2 (de) Verwendung von topisch applizierbaren Gerinnungsmaterial
DE50012379D1 (de) Verwendung von nanoskaligen antischuppenwirkstoffen
ATE239011T1 (de) Neuartige form von s-omeprazol
DE60223841D1 (de) Medizinische verwendung von gsk3-hemmenden oxindolderivaten
DE60024988D1 (de) Herstellung von therapeutischem mikroschaum
DE60039296D1 (de) System zur bestimmung der endgültigen position von zähnen
DE59810802D1 (de) Verwendung von anorganisch-organischen hybridprepolymeren
DE50007720D1 (de) Verwendung von Kammpolymeren als Schmutzablösepolymere
DE69925410D1 (de) Erweiterung des Befehlssatzes unter Verwendung von Präfixcode
DE69830591D1 (de) HEILUNG VON BRUCHVERLETZUNGEN UNTER VERWENDUNG VON PTHrP ANALOGEN
ATE301703T1 (de) Verwendung von zusammensetzungen zur textilpflege
DE69821623D1 (de) Derivate von acyl-piperazinil-pyrimidinen, ihre herstellung und verwendung als medikament
DE50212455D1 (de) Verwendung von Dimerdiolen
DE69939068D1 (de) Entfernbare implantierbare medizinische leitung
DE60019960D1 (de) Herstellung von isobutencopolymere
DE69801878D1 (de) Verwendung von Oxamatderivaten als Depigmentierungsmittel
ATA192799A (de) Neue verwendung von antikörpern als impfstoffe
DE50103536D1 (de) Verwendung von kationischen Zubereitungen
DE69912854D1 (de) Hydrierung von phthalsäuren
DK0939769T3 (da) Vertebrat-Smoothened-proteiner
DE69834262D1 (de) Neue pharnazeutische verwendung von c-c chemokin produktionsinhibitoren
ATA66799A (de) Neue medizinische verwendung von alpha1-saurem glykoprotein
DE59508900D1 (de) Verwendung von Dibrom-thiophen-carbonsäure-Derivaten als Mikrobizide
DE59904415D1 (de) Verwendung von Moxonidin als Thermogenese stimulierend wirksames Arzneimittel
DE69808866D1 (de) Herstellung von Titanschlacke

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee